BTAIBioxcel TherapeuticsBTAI info
$0.66info4.08%24h
Global rank30217
Market cap$19.41M
Change 7d-
YTD Performance-77.22%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Bioxcel Therapeutics (BTAI) Stock Overview

    BioXcel Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. Its commercial product, IGALMI, a sublingual film formulation of dexmedetomidine for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. The company also continues to conduct clinical trials evaluating BXCL501 for the acute treatment of agitation in Alzheimer's disease patients, and for adjunctive treatment of patients with major depressive disorder, as well as in the community for agitation associated with bipolar disorders and schizophrenia. In addition, it is developing BXCL502 as a potential therapy for chronic agitation in dementia; and BXCL701, an investigational, orally administered, systemic innate immunity activator for the treatment of rare forms of prostate cancer and advanced solid tumors that are refractory or treatment naïve to checkpoint inhibitors. The company was incorporated in 2017 and is headquartered in New Haven, Connecticut.

    BTAI Stock Information

    Symbol
    BTAI
    Address
    555 Long Wharf DriveNew Haven, CT 06511United States
    Founded
    -
    Trading hours
    -
    Website
    https://www.bioxceltherapeutics.com
    Country
    🇺🇸 United States
    Phone Number
    475 238 6837

    Bioxcel Therapeutics (BTAI) Price Chart

    -
    Value:-

    Bioxcel Therapeutics Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.663
    N/A
    Market Cap
    $19.41M
    N/A
    Shares Outstanding
    29.27M
    N/A
    Employees
    183.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org